Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: Higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs

American Journal of Nephrology

Volumn 27, Issue 3, 2007, Pages 226-231

  Goumenos, Dimitrios S ^a   Katopodis, Konstantinos P ^b   Passadakis, Ploumis ^c   Vardaki, Eleftheria ^d   Liakopoulos, Vasilios ^d   Dafnis, Eugenios ^d   Stefanidis, Ioannis ^d   Vargemezis, Vasilios ^c   Vlachojannis, Jannis G ^a   Siamopoulos, Kostas C ^b,e  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^e UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Ciclosporin A; Immunosuppression; Membranous glomerulonephritis; Nephrotic syndrome

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLPREDNISOLONE; CYCLOSPORIN; CYTOTOXIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; FEMALE; FIBROSING ALVEOLITIS; GINGIVA HYPERPLASIA; HUMAN; HUMAN TISSUE; INCIDENCE; INFECTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MYOPATHY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RELAPSE; REMISSION; SIDE EFFECT; DRUG COMBINATION; KIDNEY FUNCTION TEST; MIDDLE AGED; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AGED; CYCLOSPORINE; CYTOTOXINS; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34250861210     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101367     Document Type: Article

References (17)

1. Muirhead N: Management of idiopathic membranous nephropathy: evidence-based recommendations. Kidney Int Suppl 1999;70:S47-S55.
2. Cattran DC: Idiopathic membranous glomerulonephritis. Kidney Int 2001;59:1983-1994.
3. Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S: A randomised controlled trial of prednisolone in idiopathic membranous nephropathy. N Engl J Med 1989;320:210-215.
4. Cameron JS, Healy MJ, Adu D: The Medical Research Council trial of short-term high-dose alternate-day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party. Q J Med 1990;74:133-156.
5. Ponticelli C, Zucchelli P, Passerini P, et al: A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995;48:1600-1604.
6. Ponticelli C, Zucchelli P, Passerini P, Cesana B: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. N Engl J Med 1992;327:599-603.
7. Ponticelli C, Altieri P, Scolari F, et al: A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 1998;9:444-450.
8. Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB: Prednisolone and azathioprine in membranous nephropathy. Clin Nephrol 2006;65:317-323.
9. De Santo NG, Capodicasa G, Giordano C: Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporin. Am J Nephrol 1987;7:74-76.
10. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL; North American Nephrotic Syndrome Study Group: Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 2001;59:1484-1490.
11. Meyrier A, Noël LH, Auriche P, Callard P: Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie. Kidney Int 1994;45:1446-1456.
12. Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG: The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy. Clin Nephrol 2004;61:17-24.
13. Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D: Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant 2006;21:3127-3132.
14. Schwartz MM: Membranous glomerulonephritis; in Jennette JC, Olson JL, Schwartz MM (eds): Heptinstall's Pathology of the Kidney, ed 5. Philadelphia, Lippincott-Raven, 1998, pp 259-307.
15. Pirani CL, Salinas-Madrigal L: Evaluation of percutaneous renal biopsy. Pathol Annu 1968;3:249-296.
16. Korbet SM: Treatment of primary focal segmental glomerulosclerosis. Kidney Int 2002;62:2301-2310.
17. Fritsche L, Budde K, Farber L, Charisse G, Kunz R, Gaedeke J, Neumayer H: Treatment of membranous glomerulopathy with cyclosporin A: how much patience is required? Nephrol Dial Transplant 1999;14:1036-1038.